Literature DB >> 16929700

Alzheimer disease: caused by primary deficiency of the cerebral blood flow.

E Niedermeyer1.   

Abstract

Alzheimer's disease (AD) is associated with considerably decreased cerebral blood flow (CBF) thought to be secondary, since dead neurons do not need oxygen and glucose. This view, however, needs to be critically re-examined. The role of CBF in AD was submitted to a thorough analysis, raising the question: "Is there really a lack of demand in the presence of undisturbed blood supply?" CBF decline is present in AD while the number of affected CNS systems is still quite small. The step-by-step evolution of AD mirrors a brain that progressively becomes ischemic. Areas related to memory function (hippocampus, temporal lobe cortex and vicinity) are bound to suffer first because of their particularly vulnerable blood supply. This is the scenario of a disorder caused by primary and not by secondary CBF deficiency--a deficiency perhaps attributable to the upright gait of homo sapiens. This new approach also opens new avenues for treatment and prevention, which will be briefly discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16929700     DOI: 10.1177/155005940603700303

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  6 in total

1.  Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats.

Authors:  Abesh Kumar Bhattacharjee; Laura White; Lisa Chang; Kaizong Ma; G Jean Harry; Joseph Deutsch; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2012-03-16       Impact factor: 3.996

Review 2.  The pathobiology of vascular dementia.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2013-11-20       Impact factor: 17.173

3.  Alzheimer's disease and natural cognitive aging may represent adaptive metabolism reduction programs.

Authors:  Jared Edward Reser
Journal:  Behav Brain Funct       Date:  2009-02-28       Impact factor: 3.759

Review 4.  Association between risk factors for vascular dementia and adiponectin.

Authors:  Juhyun Song; Won Taek Lee; Kyung Ah Park; Jong Eun Lee
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

5.  Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people.

Authors:  Oskar Hansson; Sebastian Palmqvist; Hanna Ljung; Tobias Cronberg; Danielle van Westen; Ruben Smith
Journal:  Alzheimers Dement       Date:  2017-07-15       Impact factor: 21.566

6.  Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

Authors:  Victor Teatini Ribeiro; Thiago Macedo E Cordeiro; Roberta da Silva Filha; Lucas Giandoni Perez; Paulo Caramelli; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Ana Cristina Simões E Silva
Journal:  Front Neurosci       Date:  2021-04-06       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.